COVID-19 & Long COVID antibody biomarker discovery for assessing the immune response to diseases and its severity using ImmunoINSIGHTS™
There has been an unprecedented response to the COVID-19 pandemic to understand and respond to the effects of COVID-19, but despite vaccines now being deployed to fight the disease, the need to expand our understanding of the immune response to SARS-CoV-2 still exists. Autoimmune reactions to the virus have been shown to be a key factor in understanding disease severity and post-acute sequelae of SARS-CoV-2 infection (PASC), as long COVID.
ImmunoINSIGHTS for antibody profiling to stratify patients and predict disease severity.
ImmunoINSIGHTS Panels and Arrays for Infectious Diseases for COVID-19 and long COVID enable a better understanding of how SARS-CoV-2 stimulates an immune reaction and can predict responses to vaccines and therapeutics against the virus.
Our technology platform addresses the key challenges for:
- Patient antibody profiling before, during, and after treatment, as well as after recovery from infection
- Measuring vaccine response in animals and patients
- IgG transience in a timed manner after immunization
- Data mining support for predictive machine learning-based assay panels
A broad panel of >700 protein and peptide antigens:
- High-throughput investigation of protein-antibody interactions of multiple targets
- Assays for antibody binding to autoimmune and viral antigens, including antigens from SARS-CoV-2 and other coronaviruses (SARS-CoV-2, MERS) and other seasonal viruses (ie. influenza, rhinoviruses)
- Customizable immuno-assay panels available
The ImmunoINSIGHTS platform has demonstrated:
- Autoantibodies can be associated with disease signals many months prior to diagnosis
- Differences in antibody profile between mild, moderate, and severe symptoms
- Presence of different autoimmune activation between males and females following infection
- Differences in anti-spike peptide IgG antibodies following vaccination
- Relationship between pathways of the immune system, immune cell activation, and cytokine- mediated signaling pathways
- PASC is different from COVID-19 and shows a divergent interaction with the immune system
Explore all applications and disease areas :
- What are Autoantibodies (antibodies)?
- ImmunoINSIGHTS™ Platform
- Autoimmune Diseases
- Immuno-oncology
- Neurological Diseases
- Allergy / Dermatology
- Multiplex Serology